Syros Pharmaceuticals, Inc. (SYRS)
USD 0.21
(-0.1%)
USD 0.21
(-0.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.93 Million | 14.88 Million | 23.48 Million | 15.09 Million | 1.98 Million | 2.05 Million |
| Cost of Revenue | 108.15 Million | 2.96 Million | - | - | - | - |
| Gross Profit | -98.21 Million | 11.91 Million | 23.48 Million | 15.09 Million | 1.98 Million | 2.05 Million |
| Operating Expenses | 30.77 Million | 141.24 Million | 122.9 Million | 97.39 Million | 79.72 Million | 66.34 Million |
| Selling, General and Administrative Expenses | 28.28 Million | 29.29 Million | 23.03 Million | 21.32 Million | 21.47 Million | 16.16 Million |
| Research and Development Expenses | 108.15 Million | 111.94 Million | 99.87 Million | 76.06 Million | 58.24 Million | 50.18 Million |
| Other Expenses | -105.66 Million | -9.51 Million | - | - | 2.3 Million | 2.01 Million |
| Cost and Expenses | 138.92 Million | 141.24 Million | 122.9 Million | 97.39 Million | 79.72 Million | 66.34 Million |
| Operating Income | -128.98 Million | -135.87 Million | -99.42 Million | -82.29 Million | -77.74 Million | -64.29 Million |
| Interest Expense | 5.12 Million | 4.13 Million | 3.9 Million | 1.79 Million | - | - |
| Income Tax Expense | - | -45.35 Million | 3.9 Million | 1.79 Million | 2.55 Million | 2.01 Million |
| Earnings before Tax | -164.57 Million | -94.65 Million | -86.55 Million | -84.03 Million | -75.43 Million | -62.27 Million |
| Net Income | -164.57 Million | -49.3 Million | -90.46 Million | -85.83 Million | -75.43 Million | -62.27 Million |
| Earnings Per Share Basic | -5.81 | -3.90 | -14.47 | -18.64 | -18.76 | -19.07 |
| Earnings Per Share Diluted | -5.81 | -3.90 | -14.47 | -18.64 | -18.76 | -19.07 |
| Weighted Average Shares Outstanding | 28.32 Million | 12.63 Million | 6.25 Million | 4.6 Million | 4.02 Million | 3.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.32 Million | 12.63 Million | 6.25 Million | 4.6 Million | 4.02 Million | 3.26 Million |
| Gross Margin | -9.88 | 0.80 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -15.82 | -8.79 | -4.10 | -5.22 | -37.85 | -30.58 |
| Profit Margin | -16.56 | -3.31 | -3.85 | -5.69 | -38.06 | -30.38 |
| EBITDA | -157.19 Million | -87.55 Million | -79.63 Million | -79.21 Million | -72.71 Million | -60.67 Million |
| Earnings Before Tax Margin | -12.98 | -9.13 | -4.23 | -5.45 | -39.22 | -31.36 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 386 Thousand | 9.93 Million | 3.76 Million |
| Cost of Revenue | 325 Thousand | 331 Thousand | 334 Thousand | 279 Thousand | 2.25 Million | 616 Thousand |
| Gross Profit | -325 Thousand | -331 Thousand | -334 Thousand | 107 Thousand | 7.68 Million | 3.14 Million |
| Operating Expenses | 26.18 Million | 27.08 Million | 30.58 Million | 27.11 Million | 134.18 Million | 38.39 Million |
| Selling, General and Administrative Expenses | 5.65 Million | 5.46 Million | 6.26 Million | 5.88 Million | - | 7.76 Million |
| Research and Development Expenses | 20.52 Million | 21.62 Million | 24.32 Million | 21.22 Million | - | 28.28 Million |
| Other Expenses | - | -21.95 Million | - | 135 Thousand | 2.48 Million | 2.35 Million |
| Cost and Expenses | 26.18 Million | 27.41 Million | 30.92 Million | 27.39 Million | 136.43 Million | 38.39 Million |
| Operating Income | -26.18 Million | -27.41 Million | -30.92 Million | -27 Million | -126.49 Million | -34.63 Million |
| Interest Expense | -1.31 Million | 1.38 Million | 1.3 Million | 1.32 Million | 5.12 Million | -1.3 Million |
| Income Tax Expense | -325 Thousand | - | 290.72 Thousand | 10.88 Million | 2.08 Million | -3.29 Million |
| Earnings before Tax | -6.39 Million | -23.32 Million | -3.7 Million | -64.38 Million | -164.57 Million | -40.14 Million |
| Net Income | -6.39 Million | -23.32 Million | -3.7 Million | -64.38 Million | -164.57 Million | -40.14 Million |
| Earnings Per Share Basic | -0.16 | -0.59 | -0.10 | -2.18 | - | -1.43 |
| Earnings Per Share Diluted | -0.16 | -0.59 | -0.10 | -2.18 | - | -1.43 |
| Weighted Average Shares Outstanding | 39.26 Million | 39.26 Million | 38.97 Million | 29.54 Million | 28.32 Million | 27.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.26 Million | 39.26 Million | 38.97 Million | 29.54 Million | 28.32 Million | 27.99 Million |
| Gross Margin | - | - | - | 0.28 | 0.77 | 0.84 |
| EBIT Margin | - | - | - | -69.24 | - | -9.21 |
| Profit Margin | - | - | - | -166.80 | -16.56 | -10.67 |
| EBITDA | -26.18 Million | -27.08 Million | -30.58 Million | -26.72 Million | - | -34.63 Million |
| Earnings Before Tax Margin | - | - | - | -69.96 | -12.73 | -9.21 |
ALATI
FFMR
600469
6692
ALBHF
HPP